U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06820866) titled 'Non-invasive Diagnosis of Idiopathic Nephrotic Syndromes' on Feb. 06.
Brief Summary: Renal biopsy (RB) is the reference diagnostic procedure for Idiopathic Nephrotic Syndrome (INS). It is an invasive procedure, particularly risky during the acute phase of nephrotic syndrome when anticoagulation therapy is required.
By identifying serum antibodies that allow for the non-invasive diagnosis of the main differential diagnoses of INS, (Membranous Nephropathy), the development of a non-invasive diagnostic tool for INS could help reduce the morbidity associated with the invasive renal biopsy procedure, minimizing the risk of incorrect dia...